ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影响因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).

显示全部楼层 · 发表于 2025-3-23 18:13:24

Submitted on: 13 June 2004. Revised on: 28 August 2004. Accepted on: 24 October 2004. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-24 01:10:39

Submitted on: 27 January 2000. Revised on: 23 February 2000. Accepted on: 07 April 2000. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-24 06:18:40

显示全部楼层 · 发表于 2025-3-24 06:32:35

显示全部楼层 · 发表于 2025-3-24 12:19:04

显示全部楼层 · 发表于 2025-3-24 18:34:06

显示全部楼层 · 发表于 2025-3-24 19:42:25

Submitted on: 09 March 2006. Revised on: 09 June 2006. Accepted on: 28 June 2006. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-24 23:44:18

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-3 17:14
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影响因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).

浏览过的版块